{"id":"insulin-like-growth-factor-i","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypoglycemia"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Ear abnormalities (otitis media)"},{"rate":null,"effect":"Lymphoid tissue hypertrophy"}]},"_chembl":null,"_dailymed":{"setId":"d94be950-ce16-4c55-bbb3-af3f9c4d29d6","title":"D-136 (SOMATROPIN, LONG-(ARG3)INSULIN-LIKE GROWTH FACTOR-I, ARSENIC TRIOXIDE, SAW PALMETTO, PLATINUM, OYSTER SHELL CALCIUM CARBONATE, CRUDE, BOS TAURUS ADRENAL CORTEX, BOS TAURUS PITUITARY GLAND, POSTERIOR, THYROID, UNSPECIFIED, AND BOS TAURUS HYPOTHALAMUS) SOLUTION [DNA LABS, INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"IGF-I is a naturally occurring peptide hormone that activates the IGF-1 receptor tyrosine kinase, triggering intracellular signaling cascades that stimulate protein synthesis, cell division, and glucose uptake. It plays a critical role in growth and development, particularly in childhood, and has been used therapeutically to treat growth disorders and metabolic conditions associated with IGF-I deficiency.","oneSentence":"Insulin-like growth factor I (IGF-I) binds to the IGF-1 receptor to promote cell growth, proliferation, and metabolic effects.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T03:37:05.504Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Growth failure due to IGF-I deficiency (primary IGFD)"},{"name":"Short stature associated with severe insulin-like growth factor-I deficiency"}]},"trialDetails":[{"nctId":"NCT00921609","phase":"","title":"Peri-operative Dynamics of the Growth Hormone Axis in Subjects With Acromegaly","status":"COMPLETED","sponsor":"Cedars-Sinai Medical Center","startDate":"2006-06","conditions":"Acromegaly","enrollment":20},{"nctId":"NCT07037420","phase":"PHASE2","title":"ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly","status":"RECRUITING","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2025-10-28","conditions":"Acromegaly","enrollment":60},{"nctId":"NCT07481734","phase":"PHASE2","title":"Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)","status":"RECRUITING","sponsor":"Hudson Biotech","startDate":"2026-02-02","conditions":"Metabolic Associated Steatotic Liver Disease, Nonalcoholic Steatohepatitis, Hepatic Steatosis","enrollment":120},{"nctId":"NCT00647478","phase":"","title":"System-IGF-1 Pathway and Alzheimer's Disease","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2007-10","conditions":"Alzheimer's Disease, Mild Cognitive Impairment, Cognitive Function 1, Social","enrollment":693},{"nctId":"NCT06930625","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs","status":"RECRUITING","sponsor":"Debiopharm International SA","startDate":"2025-11-26","conditions":"Acromegaly","enrollment":119},{"nctId":"NCT06384547","phase":"PHASE3","title":"A Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED)","status":"COMPLETED","sponsor":"Viridian Therapeutics, Inc.","startDate":"2024-05-23","conditions":"Thyroid Eye Disease","enrollment":231},{"nctId":"NCT07407101","phase":"NA","title":"Impact of Filtration on Autologous Serum Eye Drops","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Limoges","startDate":"2026-04-30","conditions":"Dry Eye Syndrome (DES)","enrollment":10},{"nctId":"NCT07173036","phase":"NA","title":"Evaluation of (Cardio)Metabolic and Auxological Outcomes of GHD Patients Under rhGH or LAGH With Stratification According to IGF-1 Levels","status":"NOT_YET_RECRUITING","sponsor":"Cliniques universitaires Saint-Luc- Université Catholique de Louvain","startDate":"2026-03-01","conditions":"Growth Hormone Deficiency","enrollment":300},{"nctId":"NCT03253263","phase":"PHASE2","title":"A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants","status":"RECRUITING","sponsor":"OHB Neonatology Ltd.","startDate":"2019-05-09","conditions":"Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Intraventricular Hemorrhage","enrollment":338},{"nctId":"NCT05253287","phase":"PHASE2, PHASE3","title":"Growth Hormone in Decompensated Liver Cirrhosis","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2022-02-01","conditions":"Liver Cirrhosis, Fibrosis, End Stage Liver Disease","enrollment":96},{"nctId":"NCT07271212","phase":"NA","title":"Scalp Care Efficacy Evaluation for Premium Revitalizing Elixir","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hungkuang University","startDate":"2025-11-01","conditions":"Scalp Health, Hair Condition, Hair Loss","enrollment":60},{"nctId":"NCT07271199","phase":"NA","title":"Eyelash Effect Evaluation for Premium Rejuvenation Eyelash Serum","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hungkuang University","startDate":"2025-11-01","conditions":"Skin Condition, Eyelash Growth, Eyelashes","enrollment":30},{"nctId":"NCT00803179","phase":"PHASE1","title":"Growth Hormone Therapy for Wasting in Cystic Fibrosis","status":"TERMINATED","sponsor":"University of Massachusetts, Worcester","startDate":"2008-11","conditions":"Cystic Fibrosis","enrollment":5},{"nctId":"NCT00597480","phase":"PHASE4","title":"Study of Growth-promoting and Metabolic Effects of Growth Hormone (rhGH)","status":"TERMINATED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2008-01","conditions":"Small for Gestational Age","enrollment":10},{"nctId":"NCT06021054","phase":"PHASE3","title":"An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED) (THRIVE-2)","status":"COMPLETED","sponsor":"Viridian Therapeutics, Inc.","startDate":"2023-11-14","conditions":"Thyroid Eye Disease","enrollment":188},{"nctId":"NCT03830775","phase":"NA","title":"A Prospective Randomized Double Blinded Controlled Trial of Non-Operative Management of TFCC Injuries","status":"WITHDRAWN","sponsor":"Edna Rath","startDate":"2020-10-02","conditions":"Wrist Injuries, PRP","enrollment":""},{"nctId":"NCT07151807","phase":"","title":"Serum IGF-1 and IGF-1Ec in Malignancy Assessment","status":"ACTIVE_NOT_RECRUITING","sponsor":"Çanakkale Onsekiz Mart University","startDate":"2025-04-01","conditions":"Cancer, Solid Tumor Malignancies, IGF1R","enrollment":100},{"nctId":"NCT05645211","phase":"","title":"The AgRP and GH/IGF-1 Axis in Children","status":"NOT_YET_RECRUITING","sponsor":"Columbia University","startDate":"2026-06-10","conditions":"Growth Hormone Deficiency","enrollment":156},{"nctId":"NCT06985121","phase":"NA","title":"Scalp Care Efficacy Evaluation for Premium Scalp Revitalizing Essence","status":"COMPLETED","sponsor":"Hungkuang University","startDate":"2025-04-08","conditions":"Scalp Health, Hair Condition, Hair Loss","enrollment":60},{"nctId":"NCT03255694","phase":"PHASE2","title":"A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature","status":"ACTIVE_NOT_RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2017-05-12","conditions":"Dwarfism","enrollment":360},{"nctId":"NCT05355272","phase":"PHASE2","title":"Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT)","status":"RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2024-03-11","conditions":"Gulf War Syndrome, Adult Growth Hormone Deficiency","enrollment":20},{"nctId":"NCT05293366","phase":"","title":"LOng COvid COmorbidities: Endocrine,Metabolic,Neuropsychiatric,Muscle,Cardiovascular,Pulmonary,Dermatologic Dysfunctions","status":"RECRUITING","sponsor":"Federico II University","startDate":"2022-01-27","conditions":"Long Covid-19","enrollment":100},{"nctId":"NCT05964712","phase":"","title":"Effects of Therapies in the Acromegaly Disease: Acral Morpho-functional Study","status":"RECRUITING","sponsor":"Istituto Auxologico Italiano","startDate":"2019-06-18","conditions":"Acromegaly","enrollment":30},{"nctId":"NCT05176639","phase":"PHASE3","title":"A Safety, Tolerability and Efficacy Study of Veligrotug (VRDN 001) in Healthy Volunteers and Participants With Thyroid Eye Disease (TED) ( THRIVE )","status":"COMPLETED","sponsor":"Viridian Therapeutics, Inc.","startDate":"2021-12-03","conditions":"Thyroid Eye Disease","enrollment":113},{"nctId":"NCT05382637","phase":"PHASE2","title":"Growth Hormone in a Patient With a Dominant-Negative GHR Mutation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's National Research Institute","startDate":"2022-08-26","conditions":"Growth Disorders","enrollment":1},{"nctId":"NCT07043504","phase":"","title":"Study on Dynamic Changes of Serum IGF-1 Post-Cerebral Hemorrhage and Its Prognostic Correlation","status":"NOT_YET_RECRUITING","sponsor":"Shengjing Hospital","startDate":"2025-07-01","conditions":"Insulin-Like Growth Factor I","enrollment":100},{"nctId":"NCT07015554","phase":"","title":"Serum IGF1 on Female HFpEF Patients","status":"ENROLLING_BY_INVITATION","sponsor":"The University of Hong Kong-Shenzhen Hospital","startDate":"2025-01-01","conditions":"HFpEF - Heart Failure With Preserved Ejection Fraction","enrollment":120},{"nctId":"NCT02375620","phase":"PHASE2","title":"Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short Stature","status":"ACTIVE_NOT_RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2015-04-23","conditions":"Short Stature Children Born Small for Gestational Age (SGA)","enrollment":96},{"nctId":"NCT06564753","phase":"PHASE2","title":"Phase 2 Trials of NA-931 to Study Subjects Who Are Obese With at Least One Weight-related Comorbid Condition","status":"COMPLETED","sponsor":"Biomed Industries, Inc.","startDate":"2024-07-19","conditions":"Weight Loss, Obesity, Body Weight","enrollment":126},{"nctId":"NCT04730622","phase":"","title":"Study of Parameters of Osteosarcopenia in Patients With Hip Fracture","status":"RECRUITING","sponsor":"Istituto Ortopedico Rizzoli","startDate":"2020-11-23","conditions":"Osteoporotic Fracture of Femur, Osteoarthritis, Hip","enrollment":100},{"nctId":"NCT02507583","phase":"PHASE1","title":"Antisense102: Pilot Immunotherapy for Newly Diagnosed Malignant Glioma","status":"COMPLETED","sponsor":"david andrews","startDate":"2015-09-01","conditions":"Malignant Glioma, Neoplasms","enrollment":33},{"nctId":"NCT05187377","phase":"PHASE2","title":"A Controlled Trial of Growth Hormone in Phelan-McDermid Syndrome and Idiopathic Autism","status":"COMPLETED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2022-01-19","conditions":"Phelan-McDermid Syndrome, Autism Spectrum Disorder (ASD)","enrollment":32},{"nctId":"NCT04202094","phase":"NA","title":"Fertility in Young Adults Who Did (Not) Store Testicular Tissue Before a Treatment Leading to Fertility Problems","status":"ENROLLING_BY_INVITATION","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2020-09-08","conditions":"Childhood Cancer, Hematological Disorders","enrollment":50},{"nctId":"NCT04697264","phase":"","title":"Adipocytokines in Endometrial Cancer","status":"COMPLETED","sponsor":"University of Surrey","startDate":"2021-04-12","conditions":"Endometrial Cancer, Obesity","enrollment":100},{"nctId":"NCT02583763","phase":"","title":"Cardiac Displacement From Third Trimester to Early Childhood","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Linkoeping","startDate":"2013-01","conditions":"IUGR, Fetal Growth Retardation, Intrauterine Growth Restriction","enrollment":61},{"nctId":"NCT06869486","phase":"","title":"Insomnia´s Impact on DNA Stability, Cardio-metabolic Health and Lifestyle Behaviors","status":"RECRUITING","sponsor":"Universidad Autonoma de Baja California","startDate":"2024-10-01","conditions":"Insomnia, Cardiorespiratory Fitness, Metabolic Disease","enrollment":300},{"nctId":"NCT06850532","phase":"NA","title":"NMES Effects on Substrate Metabolism and IGF-1","status":"COMPLETED","sponsor":"Mersin University","startDate":"2017-03-17","conditions":"The Effects of Neuromuscular Electrical Stimulation on Exercise Performance","enrollment":24},{"nctId":"NCT05558384","phase":"NA","title":"Influence of Adiposity on IGF-1 and Fitness Response to Exercise in Cancer Survivors","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2023-03-22","conditions":"Cancer, Overweight and Obesity","enrollment":12},{"nctId":"NCT03932162","phase":"EARLY_PHASE1","title":"Gene Expression Changes In Young and Geriatric Skin","status":"RECRUITING","sponsor":"Wright State University","startDate":"2019-09-06","conditions":"UVB Phototherapy Burn, Insulin-like Growth Factor 1, Aging","enrollment":24},{"nctId":"NCT05869383","phase":"PHASE2, PHASE3","title":"Effect Of Ophiochepalus Striatus Extract On Serum IGF-1 And IL-6 Levels In Elderly Patients With Sarcopenia","status":"COMPLETED","sponsor":"Universitas Sriwijaya","startDate":"2023-05-01","conditions":"Sarcopenia, Geriatric, Muscle Mass","enrollment":80},{"nctId":"NCT06522074","phase":"","title":"Evaluating the Role of IGF-1 and S-Klotho In Plaque Phenotype and Vulnerability: the VISION Study.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2024-10-15","conditions":"Ischemic Heart Disease, Chronic Coronary Syndrome, Optical Coherence Tomography (OCT)","enrollment":150},{"nctId":"NCT04531410","phase":"NA","title":"NETwork of Linoleic Acid Supplementation in Cystic Fibrosis","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2021-10-25","conditions":"Cystic Fibrosis","enrollment":50},{"nctId":"NCT02431676","phase":"PHASE2","title":"Survivorship Promotion In Reducing IGF-1 Trial","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2015-05","conditions":"Breast Cancer, Prostate Cancer, Lung Cancer","enrollment":121},{"nctId":"NCT01424241","phase":"PHASE4","title":"Effects of Sandostatin LAR® in Acromegaly","status":"COMPLETED","sponsor":"Columbia University","startDate":"2006-10","conditions":"Acromegaly","enrollment":21},{"nctId":"NCT00684957","phase":"PHASE1, PHASE2","title":"Differential Effects of rhGH vs. rhIGF-1 on Cardiovascular Risk Factors","status":"TERMINATED","sponsor":"Columbia University","startDate":"2008-01","conditions":"Growth Hormone Deficiency","enrollment":5},{"nctId":"NCT04054505","phase":"NA","title":"Effectiveness of a Nutraceutical in Raising Circulating Serum Vitamin, Mineral and Amino Acid Levels in Patients.","status":"COMPLETED","sponsor":"Optimal Health Research","startDate":"2019-01-02","conditions":"Vitamin Deficiency","enrollment":275},{"nctId":"NCT06456645","phase":"","title":"Effects of Smoking on Placenta and Lactation","status":"COMPLETED","sponsor":"Celal Bayar University","startDate":"2017-05-01","conditions":"Smoking, Tobacco, Placenta Diseases, Breastfeeding","enrollment":70},{"nctId":"NCT06426524","phase":"NA","title":"Efficacy of Insulin Like Growth Factor-1(IGF-1) on Bone Regeneration in Intrabony Defects : A Clinico-radiograph Study","status":"RECRUITING","sponsor":"Dr R Viswa Chandra","startDate":"2023-05-19","conditions":"Intrabony Periodontal Defect","enrollment":24},{"nctId":"NCT04003207","phase":"PHASE2","title":"Growth Hormone Treatment in Children With Phelan McDermid Syndrome","status":"COMPLETED","sponsor":"Swathi Sethuram","startDate":"2019-09-13","conditions":"Phelan McDermid Syndrome","enrollment":6},{"nctId":"NCT06094998","phase":"","title":"Health Status of Children Born After Assisted Reproductive Technologies","status":"COMPLETED","sponsor":"Kazakhstan's Medical University \"KSPH\"","startDate":"2023-10-18","conditions":"Children Born After Assisted Reproductive Technologies, Health Status, Child Development","enrollment":252},{"nctId":"NCT02636270","phase":"PHASE1, PHASE2","title":"IGF-1 Treatment for Individuals With Short Stature Due to PAPP-A2 Deficiency","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2015-12-21","conditions":"Short Stature","enrollment":7},{"nctId":"NCT06275373","phase":"","title":"The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction","status":"RECRUITING","sponsor":"Walter Reed National Military Medical Center","startDate":"2021-05-12","conditions":"Thyroid Eye Disease, Graves Ophthalmopathy, Graves Disease","enrollment":100},{"nctId":"NCT01970345","phase":"PHASE2","title":"A Pilot Treatment Study of Insulin-Like Growth Factor-1 (IGF-1) in Autism Spectrum Disorder","status":"TERMINATED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2014-05","conditions":"Autism Spectrum Disorder","enrollment":3},{"nctId":"NCT05812079","phase":"","title":"Insulin Like Growth Factor-1 Against Oxidative Stress in Vitiligo","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2024-02-01","conditions":"Vitiligo","enrollment":33},{"nctId":"NCT06114550","phase":"NA","title":"Resistance Training on Growth Factors","status":"UNKNOWN","sponsor":"Air Force Military Medical University, China","startDate":"2024-02-27","conditions":"Cognitive Function","enrollment":12},{"nctId":"NCT05612802","phase":"NA","title":"A New Marker for Early Diagnosis of Pneumoperitoneum-Related Acute Kidney Injury: Insulin-Like Growth Factor-1 (IGF-1)","status":"COMPLETED","sponsor":"Baskent University","startDate":"2023-02-08","conditions":"Acute Kidney Injury (Nontraumatic), Pneumoperitoneum","enrollment":25},{"nctId":"NCT05301569","phase":"","title":"Relation Between Serum IGF-1 & BMI In Acne Vulgaris","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2023-04-01","conditions":"Evaluation of Serum Level of Insulin Like Growth Factor 1","enrollment":90},{"nctId":"NCT04349839","phase":"","title":"ACRODAT Prospective Evaluation Study","status":"UNKNOWN","sponsor":"University of Aarhus","startDate":"2020-01-15","conditions":"Acromegaly","enrollment":500},{"nctId":"NCT06071403","phase":"","title":"The Effects of Time Points to Cease Parenteral Nutrition and IGF-1 on Very Low Birth Weight Infants","status":"RECRUITING","sponsor":"Peking University","startDate":"2023-07-01","conditions":"Growth Retardation","enrollment":416},{"nctId":"NCT06014398","phase":"NA","title":"Improving Survivorship and Health-related Quality of Life in Patients With Primary Brain Tumours","status":"UNKNOWN","sponsor":"Royal College of Surgeons, Ireland","startDate":"2023-09-01","conditions":"Hypopituitarism, Radiotherapy-Induced Hypopituitarism, Brain Tumor","enrollment":50},{"nctId":"NCT00673309","phase":"PHASE2, PHASE3","title":"Assessment of Mechanisms of Improved Wound Healing","status":"COMPLETED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2000-07","conditions":"Burns","enrollment":644},{"nctId":"NCT05333133","phase":"NA","title":"High Calorie Formula Intervention on Weight, Length Increment, Total Lymphocyte Counts, TNF-alpha and IGF-1 in Failure to Thrive Children","status":"COMPLETED","sponsor":"Universitas Airlangga","startDate":"2021-10-04","conditions":"Failure to Thrive, Infection, Bacterial, Growth Faltering","enrollment":80},{"nctId":"NCT01721577","phase":"PHASE1, PHASE2","title":"Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas","status":"TERMINATED","sponsor":"Rush University Medical Center","startDate":"2012-12","conditions":"Glioblastoma, Gliosarcoma, Anaplastic Astrocytoma","enrollment":10},{"nctId":"NCT03420144","phase":"PHASE2, PHASE3","title":"Growth Hormone Therapy in Liver Cirrhosis","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2018-01-15","conditions":"Cirrhosis, Liver","enrollment":76},{"nctId":"NCT05144035","phase":"PHASE4","title":"A Real World Study of the Effect of Early PEG-rhGH Therapy on Cognitive Development of SGA Infants","status":"RECRUITING","sponsor":"Tongji Hospital","startDate":"2022-04-06","conditions":"Small for Gestational Age Infant, Growth Hormone Treatment, Cognitive Developmental Disorder","enrollment":138},{"nctId":"NCT00572156","phase":"PHASE2","title":"rhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 Deficiency","status":"TERMINATED","sponsor":"Ipsen","startDate":"2007-12","conditions":"Insulin-like Growth Factor-1 Deficiency","enrollment":106},{"nctId":"NCT05788822","phase":"NA","title":"MVA to Improve the Pregnancy Outcome in Aged Infertility Women With Assisted Reproductive Technology","status":"UNKNOWN","sponsor":"Nanjing University","startDate":"2022-10-08","conditions":"Infertility, Female, IVF, Reproductive Disorder","enrollment":148},{"nctId":"NCT05004389","phase":"","title":"Biomarkers of Independent Walking Post-Stroke","status":"UNKNOWN","sponsor":"University of Vermont","startDate":"2021-12-02","conditions":"Stroke, Acute, Gait, Hemiplegic","enrollment":35},{"nctId":"NCT05750303","phase":"","title":"Potential Prognostic Markers of Recovery in Post-stroke Rehabilitation","status":"COMPLETED","sponsor":"Medical University of Lodz","startDate":"2022-01-02","conditions":"Ischemic Stroke","enrollment":32},{"nctId":"NCT04143204","phase":"","title":"Nutrition and Growth in Very Preterm Infants","status":"COMPLETED","sponsor":"Children's Hospital of Fudan University","startDate":"2019-08-01","conditions":"Premature, Growth","enrollment":180},{"nctId":"NCT05038306","phase":"PHASE2","title":"Chinese Medicine WT for Spinocerebellar Ataxia Type 3","status":"COMPLETED","sponsor":"Changhua Christian Hospital","startDate":"2021-05-31","conditions":"Ataxia, Spinocerebellar, Insulin-Like Growth Factor I, Medicine, Chinese Traditional","enrollment":33},{"nctId":"NCT02152124","phase":"","title":"Growth Hormone, IGF-1 and Medical Treatment in Acromegaly: Are There Effects on Gut Hormone Physiology and Postprandial Substrate Metabolism?","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2014-06-01","conditions":"Acromegaly","enrollment":21},{"nctId":"NCT04021017","phase":"PHASE1","title":"PRE-GAiN Bone Health Pilot Study","status":"WITHDRAWN","sponsor":"University of Saskatchewan","startDate":"2020-01-21","conditions":"Anorexia Nervosa","enrollment":""},{"nctId":"NCT05642169","phase":"NA","title":"Effect of a HIIT Program on Quality of Life, Executive Functions, and IGF-1 Response in Sedentary Young University Women","status":"UNKNOWN","sponsor":"University of Seville","startDate":"2022-10-15","conditions":"Insulin Growth Factor I Deficiency, IGF1 Deficiency, Executive Function Disorder","enrollment":75},{"nctId":"NCT02217345","phase":"PHASE2","title":"Growth Hormone and Intrahepatic Lipid Content in Patients With Nonalcoholic Fatty Liver Disease","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2017-06-02","conditions":"Nonalcoholic Fatty Liver Disease (NAFLD)","enrollment":131},{"nctId":"NCT02726542","phase":"EARLY_PHASE1","title":"Augmenting Growth Hormone to Ameliorate Nonalcoholic Fatty Liver Disease in Adolescents","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2017-05-03","conditions":"NAFLD","enrollment":24},{"nctId":"NCT05529550","phase":"","title":"Assessment of Nutritional Status and Role of Insulin-like Growth Factor-1 in Children","status":"COMPLETED","sponsor":"Menoufia University","startDate":"2020-10-01","conditions":"Thalassemia","enrollment":102},{"nctId":"NCT03610412","phase":"PHASE3","title":"Cinnamomum Cassia Effect on IGF1 and Metabolic Control in Patients With DM2 Without Glycemic Control Metformin Treated","status":"COMPLETED","sponsor":"Coordinación de Investigación en Salud, Mexico","startDate":"2019-08-01","conditions":"Diabetes Mellitus, Type 2","enrollment":28},{"nctId":"NCT05390073","phase":"","title":"Growth Hormone in EB","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2022-05-25","conditions":"Epidermolysis Bullosa Dystrophica","enrollment":50},{"nctId":"NCT02386839","phase":"PHASE2","title":"Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROPP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP)","status":"COMPLETED","sponsor":"Shire","startDate":"2015-03-26","conditions":"Retinopathy of Prematurity (ROP)","enrollment":76},{"nctId":"NCT01525901","phase":"PHASE2","title":"Clinical Trial in 22q13 Deletion Syndrome(Phelan-McDermid Syndrome)","status":"COMPLETED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2012-02","conditions":"22q13 Deletion Syndrome, Phelan-McDermid Syndrome","enrollment":19},{"nctId":"NCT03041701","phase":"PHASE1, PHASE2","title":"Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2017-07-07","conditions":"Rhabdomyosarcoma, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal","enrollment":14},{"nctId":"NCT02410343","phase":"PHASE3","title":"Study of TV-1106 in Growth Hormone-Deficient Adults","status":"TERMINATED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2015-04-30","conditions":"Growth Hormone Deficiency","enrollment":14},{"nctId":"NCT00577577","phase":"PHASE2","title":"Safety and Efficacy Study of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) In Myotonic Dystrophy Type 1","status":"COMPLETED","sponsor":"Insmed Incorporated","startDate":"2007-12","conditions":"Myotonic Dystrophy Type 1","enrollment":69},{"nctId":"NCT01811576","phase":"PHASE2","title":"Safety, Tolerability and Efficacy of Weekly TV-1106 in Adults With Growth Hormone Deficiency","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2013-03-31","conditions":"Growth Hormone Deficiency","enrollment":52},{"nctId":"NCT02952885","phase":"PHASE3","title":"Strict IGF-1 Control in Acromegaly","status":"COMPLETED","sponsor":"Unity Health Toronto","startDate":"2017-07-27","conditions":"Acromegaly","enrollment":10},{"nctId":"NCT00516386","phase":"PHASE1, PHASE2","title":"Safety Profile of Insulin Like Growth Factor-1 (IGF-I) Administration in Adolescents","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2007-03","conditions":"Anorexia Nervosa","enrollment":16},{"nctId":"NCT05100550","phase":"NA","title":"Family-based Health Education Program and Zinc Supplementation for Stunted Mother","status":"UNKNOWN","sponsor":"Hasanuddin University","startDate":"2020-09-01","conditions":"Stunting, Maternal-Fetal Relations","enrollment":126},{"nctId":"NCT00171730","phase":"PHASE2","title":"An Extension Study to Assess the Long-Term Safety and Efficacy of Pasireotide in Participants With Acromegaly","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2004-08-24","conditions":"Acromegaly","enrollment":30},{"nctId":"NCT03384719","phase":"NA","title":"The Effect of Milk Protein vs Blends of Milk and Plant Protein on Growth Markers in 7-8 Year Old Healthy Danish Children","status":"COMPLETED","sponsor":"University of Copenhagen","startDate":"2018-01-18","conditions":"Growth Acceleration, Growth; Stunting, Nutritional","enrollment":129},{"nctId":"NCT04123782","phase":"NA","title":"Focused Shockwave Treatment in the Recovery Process of Acute Muscle Injuries in Soccer Players","status":"COMPLETED","sponsor":"Fundación Garcia Cugat","startDate":"2019-06-29","conditions":"Muscle Injury","enrollment":60},{"nctId":"NCT01301183","phase":"PHASE3","title":"Effects of Anorexia Nervosa on Peak Bone Mass","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2011-02","conditions":"Anorexia Nervosa","enrollment":75},{"nctId":"NCT03225040","phase":"","title":"Bone MicroArchitecture in Acromegaly","status":"COMPLETED","sponsor":"Columbia University","startDate":"2016-08-03","conditions":"Acromegaly, Osteoporosis Risk","enrollment":77},{"nctId":"NCT01096784","phase":"PHASE2","title":"IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity","status":"COMPLETED","sponsor":"Shire","startDate":"2010-06-18","conditions":"Retinopathy of Prematurity (ROP)","enrollment":121},{"nctId":"NCT04860037","phase":"","title":"Micromegaly and Discrepancy Between Growth Hormone and IGF1 at the Diagnosis and Follow-up of Acromegalic Patients","status":"UNKNOWN","sponsor":"University Hospital, Montpellier","startDate":"2010-01-01","conditions":"Acromegaly","enrollment":250},{"nctId":"NCT01322802","phase":"PHASE1","title":"Vaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian Cancer","status":"COMPLETED","sponsor":"University of Washington","startDate":"2012-03-06","conditions":"Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor, Stage IV Ovarian Epithelial Cancer","enrollment":25},{"nctId":"NCT03616509","phase":"PHASE4","title":"GH in Adults With PWS, Effect on Hypotonia Evaluated by Functional MRI, Relationship With Strength and Body Composition","status":"COMPLETED","sponsor":"Corporacion Parc Tauli","startDate":"2017-06-19","conditions":"Prader-Willi Syndrome","enrollment":30},{"nctId":"NCT01207908","phase":"PHASE1, PHASE2","title":"Safety and Efficacy Study of IGF-1 in Duchenne Muscular Dystrophy","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2010-11","conditions":"Duchenne Muscular Dystrophy","enrollment":44},{"nctId":"NCT04710745","phase":"","title":"Atrial Fibrillation in Relationship to Plasma Biomarkers","status":"UNKNOWN","sponsor":"Premedix Academy","startDate":"2020-12-04","conditions":"Atrial Fibrillation","enrollment":300},{"nctId":"NCT04710186","phase":"","title":"AR, IGF-IR, IR and Peripheral Artery Disease","status":"UNKNOWN","sponsor":"University of Catanzaro","startDate":"2018-08-01","conditions":"Androgen Receptor Abnormal, Insulin-Like Growth Factor I Deficiency, Insulin Receptor, Defect in","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":15063,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"insulin-like growth factor I","genericName":"insulin-like growth factor I","companyName":"Children's Hospital of Philadelphia","companyId":"children-s-hospital-of-philadelphia","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Insulin-like growth factor I (IGF-I) binds to the IGF-1 receptor to promote cell growth, proliferation, and metabolic effects. Used for Growth failure due to IGF-I deficiency (primary IGFD), Short stature associated with severe insulin-like growth factor-I deficiency.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}